VEGFR-2-IN-36
VEGFR-2-IN-36 (compound 15) is a VEGFR-2 inhibitor (IC50: 0.067 μM) and inducer of apoptosis with anticancer activity. VEGFR-2-IN-36 upregulates BAX levels and downregulates Bcl-2 levels. VEGFR-2-IN-36 is toxic to cancer cells, MCF-7 (IC50=0.42 μM) and HepG2 (IC50=0.22 μM) [1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; VEGFR
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vegfr-2-in-36.html
Solubility
10 mM in DMSO
Smiles
CN(C=N1)C2=C1N(C)C(N(CC(NC3=CC=C(/C(C)=N/NC(C4=CC=C(O)C=C4)=O)C=C3)=O)C2=O)=O
Molecular Formula
C24H23N7O5
Molecular Weight
489.48
References & Citations
[1]Eissa IH, et al. Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers. Comput Biol Chem. 2023 Aug 30;107:107953.. .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP52394PU-N 400 µL
Kallikrein 9 (KLK9) (Center) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC402030-100 1x 100 µL
Catenin, beta (CTNNB1) (CTNNB1/2030R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details